---
figid: PMC8136123__IJMM-48-01-04964-g04
figtitle: 'Histone deacetylase-2: A potential regulator and therapeutic target in
  liver disease (Review)'
organisms:
- NA
pmcid: PMC8136123
filename: IJMM-48-01-04964-g04.jpg
figlink: /pmc/articles/PMC8136123/figure/f5-ijmm-48-01-04964/
number: F5
caption: Schematic representation of the role of HDAC2 in HCC. Treatment with EGF
  increases CK2α expression and phosphorylation of mTOR and AKT, inducing expression
  of HDAC2 in HCC. In addition, elevated expression of HDAC2 triggers a positive feedback
  loop of AKT phosphorylation via transcriptional modulation of phosphoinositide signaling
  molecules. Furthermore, 1,25(OH)2D3 inhibits the growth of HCC cells via downregulating
  HDAC2-mediated PTEN upregulation, and upregulating p21 (WAFI/CIP1), AKT deactivation
  and inhibition of the PI3K/AKT signaling pathway. HDAC2, histone deacetylase 2;
  CK2α, casein kinase II; HCC, hepatocellular carcinoma.
papertitle: 'Histone deacetylase-2: A potential regulator and therapeutic target in
  liver disease (Review).'
reftext: Ya-Ru Liu, et al. Int J Mol Med. 2021 Jul;48(1):131.
year: '2021'
doi: 10.3892/ijmm.2021.4964
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: histone deacetylase 2 | liver disease | inhibitor | non-coding RNA
automl_pathway: 0.9418384
figid_alias: PMC8136123__F5
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8136123__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8136123__IJMM-48-01-04964-g04.html
  '@type': Dataset
  description: Schematic representation of the role of HDAC2 in HCC. Treatment with
    EGF increases CK2α expression and phosphorylation of mTOR and AKT, inducing expression
    of HDAC2 in HCC. In addition, elevated expression of HDAC2 triggers a positive
    feedback loop of AKT phosphorylation via transcriptional modulation of phosphoinositide
    signaling molecules. Furthermore, 1,25(OH)2D3 inhibits the growth of HCC cells
    via downregulating HDAC2-mediated PTEN upregulation, and upregulating p21 (WAFI/CIP1),
    AKT deactivation and inhibition of the PI3K/AKT signaling pathway. HDAC2, histone
    deacetylase 2; CK2α, casein kinase II; HCC, hepatocellular carcinoma.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - HDAC2
  - HCC
  - HYCC1
  - MTOR
  - NFKB1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - PTEN
---
